Journal article icon

Journal article

Partnership and consent in MS treatment choice.

Abstract:

It is not only good medical practice to ensure patients are fully involved in their treatment decisions, but it also improves subsequent compliance, and may even be cost effective. However, choosing treatments in MS is becoming increasingly complex, which means that ensuring patients understand all the issues is a challenge and time consuming. Preference sensitive care (which applies to current MS immunomodulatory treatments) is particularly vulnerable to the individual doctor's opinion and t...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1016/j.jns.2013.09.001

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience
Role:
Author
Journal:
Journal of the neurological sciences
Volume:
335
Issue:
1-2
Pages:
5-8
Publication date:
2013-12-05
DOI:
EISSN:
1878-5883
ISSN:
0022-510X
URN:
uuid:6bc0f5eb-1550-4c63-9873-c6b4a79d69fd
Source identifiers:
431369
Local pid:
pubs:431369

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP